Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
Rheumatology, 10/08/09
Köller MD et al. –This study compared the efficacy of MTX and MTX+TNF inhibitors (TNFis) in elderly patients with RA with that in patients of younger age. Responsiveness of elderly patients with RA to MTX or TNFi+MTX is similar to that observed in patients of younger age
Methods- Data from 2 large, randomized, controlled, double-blind trials in patients with early RA using adalimumab or infliximab+MTX or MTX alone obtained and pooled
- Composite disease activity indices calculated at baseline and 1 year of treatment
- Compared in groups of patients classified by quartiles of age with highest age group comprising 61–82 years using analysis of variance or Kruskal–Wallis test
- Across all age quartiles, improvement on MTX similar with respect to changes of composite disease activity indices, assessment of physical function and X-ray progression
- TNFi+MTX had similar effects across all age groups
- Effects of combination more profound than those of MTX monotherapy
- In 10% of patients with highest age, primarily septuagenarians, improvement was seen to a similar degree as in younger ones
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines
World Journal of Biological Psychiatry, 12/10/09
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
An Open Pilot Study Assessing the Benefits of Quetiapine for the Prevention of Migraine Refractory to the Combination of Atenolol, Nortriptyline, and Flunarizine
Pain Medicine, 12/10/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?
Pain Research and Management, 12/10/09
Alendronate reduces osteoclast precursors in osteoporosis
Osteoporosis International, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


